Recombinant Human STEAP1 cell lysate

• Cat.No.: STEAP1-1710HCL

Specification

• Description: This gene is predominantly expressed in prostate tissue, and is found to be upregulated in multiple cancer cell lines. The gene product is predicted to be a six-transmembrane protein, and was shown to be a cell surface antigen significantly expressed at cell-cell junctions.
• Species: Human
• Size: 100 ul
• Storage Buffer: 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
• Applications: Western Blot

Gene Information

• Gene Name: STEAP1 six transmembrane epithelial antigen of the prostate 1 [ Homo sapiens ]
• Official Symbol: STEAP1
• Synonyms: STEAP1; six transmembrane epithelial antigen of the prostate 1; six transmembrane epithelial antigen of the prostate , STEAP; metalloreductase STEAP1; PRSS24; six-transmembrane epithelial antigen of prostate 1; STEAP; MGC19484
• Gene ID: 26872
• mRNA Refseq: NM_012449
• Protein Refseq: NP_036581
• MIM: 604415
• UniProt ID: Q9UHE8
• Chromosome Location: 7q21
• Pathway: Mineral absorption, organism-specific biosystem; Mineral absorption, conserved biosystem
• Function: channel activity; electron carrier activity; flavin adenine dinucleotide binding; iron ion binding; metal ion binding; oxidoreductase activity; transporter activity

Reviews

09/10/2020

I am confident that the STEAP1 protein will unlock vital insights into cellular processes, propelling my scientific investigations to new heights.

10/22/2016

The STEAP1 protein stands as a remarkable solution that exemplifies exceptional quality and meets all my experimental requirements.

04/18/2016

Its impressive purity and functional characteristics make it an ideal choice for my research endeavors, ensuring reliable and impactful results.

Q&As

Can STEAP1 protein be used for cancer screening?

Studies suggest that STEAP1 protein levels can be used as a biomarker for cancer screening and early detection.

What are the implications of STEAP1 protein in drug resistance?

Understanding the role of STEAP1 in drug resistance may lead to the development of combination therapies to overcome resistance in cancer treatment.

How is STEAP1 protein being studied in clinical trials?

Clinical trials are exploring the use of STEAP1-targeted therapies in various cancer types, including prostate, bladder, and breast cancer.

Are there any drugs targeting STEAP1 protein?

Several studies are investigating the use of targeted therapies and immunotherapies that specifically target STEAP1 in cancer treatment.

How does STEAP1 protein affect tumor growth and metastasis?

Studies have suggested that STEAP1 may play a role in promoting tumor growth and metastasis, making it an attractive target for cancer therapy.